Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 710

2.

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.

Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, Ahn H.

Sci Rep. 2019 Jun 5;9(1):8305. doi: 10.1038/s41598-019-44504-9.

3.

Comparison and correlation among in vitro and in vivo assays to assess cord blood quality according to delivery temperature and time after collection.

Maeng JY, Kim SY, An BY, Kim S, Lee JL, Oh IH, Kim TG.

Transfus Apher Sci. 2019 May 22. pii: S1473-0502(19)30076-X. doi: 10.1016/j.transci.2019.05.006. [Epub ahead of print]

PMID:
31147270
4.

Oncologic Outcomes of Organ Preserving Approaches in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy.

Park IJ, Lee JL, Yoon YS, Kim CW, Lim SB, Yu CS, Kim JC.

Ann Coloproctol. 2019 Apr;35(2):65-71. doi: 10.3393/ac.2019.03.17. Epub 2019 Apr 30.

5.

Local Housing Characteristics Associated with Early Childhood Development Outcomes in Australian Disadvantaged Communities.

Villanueva K, Badland H, Tanton R, Katz I, Brinkman S, Lee JL, Woolcock G, Giles-Corti B, Goldfeld S.

Int J Environ Res Public Health. 2019 May 16;16(10). pii: E1719. doi: 10.3390/ijerph16101719.

6.

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.

Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ; IMmotion151 Study Group.

Lancet. 2019 May 9. pii: S0140-6736(19)30723-8. doi: 10.1016/S0140-6736(19)30723-8. [Epub ahead of print]

PMID:
31079938
7.

Nylon mesh-based sample holder for fixed-target serial femtosecond crystallography.

Lee D, Baek S, Park J, Lee K, Kim J, Lee SJ, Chung WK, Lee JL, Cho Y, Nam KH.

Sci Rep. 2019 May 6;9(1):6971. doi: 10.1038/s41598-019-43485-z.

8.

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up.

Fradet Y, Bellmunt J, Vaughn DJ, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Nam K, Frenkl TL, Perini RF, de Wit R, Bajorin DF.

Ann Oncol. 2019 May 3. pii: mdz127. doi: 10.1093/annonc/mdz127. [Epub ahead of print]

PMID:
31050707
9.

3'-Deoxy-3'-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies.

Kim JE, Chae SY, Kim JH, Kim HJ, Kim TW, Kim KP, Kim SY, Lee JL, Oh SJ, Kim JS, Ryu JS, Moon DH, Hong YS.

Eur J Nucl Med Mol Imaging. 2019 Apr 30. doi: 10.1007/s00259-019-04330-7. [Epub ahead of print]

PMID:
31041456
10.

Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.

Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, Park SH, Lee JS, Hong YS, Kim SY, Kim JE, Kim JH, Park JH, Kim J, Han M.

BMC Cancer. 2019 Apr 29;19(1):404. doi: 10.1186/s12885-019-5581-9.

11.

Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.

Cho E, Park IJ, Hong SM, Lee JL, Kim CW, Yoon YS, Lim SB, Yu CS, Kim JC.

Clin Colorectal Cancer. 2019 Jun;18(2):e171-e178. doi: 10.1016/j.clcc.2019.03.003. Epub 2019 Apr 2.

12.

Lactobacillus plantarum HY7714 Restores TNF-α Induced Defects on Tight Junctions.

Nam B, Kim SA, Nam W, Jeung WH, Park SD, Lee JL, Sim JH, Jang SS.

Prev Nutr Food Sci. 2019 Mar;24(1):64-69. doi: 10.3746/pnf.2019.24.1.64. Epub 2019 Mar 31.

13.

An audit of the practice of electroconvulsive therapy (ECT) in a Victorian Health Service before and after the Mental Health Act 2014.

Lee JL.

Australas Psychiatry. 2019 Apr;27(2):197. doi: 10.1177/1039856218810163. No abstract available.

PMID:
30994031
14.

Antiviral activity of pinocembrin against Zika virus replication.

Lee JL, Loe MWC, Lee RCH, Chu JJH.

Antiviral Res. 2019 Jul;167:13-24. doi: 10.1016/j.antiviral.2019.04.003. Epub 2019 Apr 5.

PMID:
30959074
15.

Transthyretin (Prealbumin) and the Ambiguous Nature of Malnutrition.

Lee JL, Finucane TE.

J Hosp Med. 2019 Apr;14(4):257-258. doi: 10.12788/jhm.3144. No abstract available.

PMID:
30933681
16.

Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.

Kim M, Kim JK, Lee J, Kim YS, Lee JL, Kwak C, Jeong CW, Byun SS, Lee SC, Ohyama C, Arai Y, Ahn H.

Int J Radiat Oncol Biol Phys. 2019 Mar 26. pii: S0360-3016(19)30386-4. doi: 10.1016/j.ijrobp.2019.03.027. [Epub ahead of print]

PMID:
30922943
17.

Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.

Lee JL, Roh SA, Kim CW, Kwon YH, Ha YJ, Kim SK, Kim SY, Cho DH, Kim YS, Kim JC.

World J Gastroenterol. 2019 Mar 21;25(11):1341-1354. doi: 10.3748/wjg.v25.i11.1341.

18.

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.

Choi Y, Keam B, Kim M, Yoon S, Kim D, Choi JG, Seo JY, Park I, Lee JL.

Cancer Res Treat. 2019 Mar 25. doi: 10.4143/crt.2019.086. [Epub ahead of print]

19.

Benefits of repeated resections for liver and lung metastases from colorectal cancer.

Yang KM, Park IJ, Lee JL, Kim CW, Yoon YS, Lim SB, Yu CS, Kim JC.

Asian J Surg. 2019 Mar 23. pii: S1015-9584(18)30713-9. doi: 10.1016/j.asjsur.2019.03.002. [Epub ahead of print]

20.

Practical Guidelines for Hyaluronic Acid Soft-Tissue Filler Use in Facial Rejuvenation.

Lee W, Hwang SG, Oh W, Kim CY, Lee JL, Yang EJ.

Dermatol Surg. 2019 Feb 18. doi: 10.1097/DSS.0000000000001858. [Epub ahead of print]

PMID:
30883477
21.

Variation in the Height of Rectal Cancers According to the Diagnostic Modalities.

Yeom SS, Park IJ, Yang DH, Lee JL, Yoon YS, Kim CW, Lim SB, Park SH, Kim HJ, Yu CS, Kim JC.

Ann Coloproctol. 2019 Feb;35(1):24-29. doi: 10.3393/ac.2018.07.31. Epub 2019 Feb 28.

22.

Does the Different Locations of Colon Cancer Affect the Oncologic Outcome? A Propensity-Score Matched Analysis.

Yang KM, Park IJ, Lee JL, Yoon YS, Kim CW, Lim SB, Kim NY, Hong S, Yu CS, Kim JC.

Ann Coloproctol. 2019 Feb;35(1):15-23. doi: 10.3393/ac.2018.07.25. Epub 2019 Feb 28.

23.

Intestinal endometriosis: Diagnostic ambiguities and surgical outcomes.

Bong JW, Yu CS, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Kim JC.

World J Clin Cases. 2019 Feb 26;7(4):441-451. doi: 10.12998/wjcc.v7.i4.441.

24.

Rural and Urban Differences in the Adoption of New Health Information and Medical Technologies.

Haggstrom DA, Lee JL, Dickinson SL, Kianersi S, Roberts JL, Teal E, Baker LB, Rawl SM.

J Rural Health. 2019 Mar;35(2):144-154. doi: 10.1111/jrh.12358. Epub 2019 Mar 4.

PMID:
30830983
25.

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.

Park JH, Lee JS, Koo H, Kim JE, Ahn JH, Ryu MH, Park SR, Yoon SK, Lee JC, Hong YS, Kim SY, Kim KP, Yoo CH, Hong JY, Lee JL, Jung KH, Rhyoo BY, Kim TW.

J Cancer Educ. 2019 Feb 28. doi: 10.1007/s13187-019-01494-6. [Epub ahead of print]

PMID:
30820925
26.

Correction to: The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.

Yoo SH, Yun YH, Kim KN, Lee JL, Park J, Choi YS, Lim YK, Kim S, Jeong HS, Kang JH, Oh HS, Park JC, Kim SY, Song HS, Lee KS, Heo DS, Hong YS.

Qual Life Res. 2019 Jun;28(6):1693. doi: 10.1007/s11136-019-02124-w.

PMID:
30790153
27.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH Jr, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK.

N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16.

PMID:
30779531
28.

The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.

Yu CS, Jung SW, Lee JL, Lim SB, Park IJ, Yoon YS, Kim CW, Ynag SK, Ye BD, Park SH, Han M, Kim JC.

Inflamm Bowel Dis. 2019 Feb 8. doi: 10.1093/ibd/izz010. [Epub ahead of print]

PMID:
30753560
29.

Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.

Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, Ahn H.

Clin Genitourin Cancer. 2019 Jun;17(3):e420-e428. doi: 10.1016/j.clgc.2019.01.001. Epub 2019 Jan 9.

PMID:
30713014
30.

Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma.

Hwang HS, Go H, Park JM, Yoon SY, Lee JL, Jeong SU, Cho YM.

Lab Invest. 2019 May;99(5):659-670. doi: 10.1038/s41374-019-0188-y. Epub 2019 Jan 25.

PMID:
30683903
31.

Training and accreditation standards for pathologists undertaking clinical trial work.

Rees G, Salto-Tellez M, Lee JL, Oien K, Verrill C, Freeman A, Mirabile I, West NP; National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group.

J Pathol Clin Res. 2019 Apr;5(2):100-107. doi: 10.1002/cjp2.124. Epub 2019 Feb 27.

32.

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacilllus paracasei HP7.

Hong SS, Lee HA, Kim JY, Jeong JW, Shim JJ, Lee JL, Sim JH, Chung Y, Kim O.

Lab Anim Res. 2018 Dec;34(4):216-222. doi: 10.5625/lar.2018.34.4.216. Epub 2018 Dec 31.

33.

Different temporal windows for CB1 receptor involvement in contextual fear memory destabilisation in the amygdala and hippocampus.

Lee JLC, Amorim FE, Cassini LF, Amaral OB.

PLoS One. 2019 Jan 15;14(1):e0205781. doi: 10.1371/journal.pone.0205781. eCollection 2019.

34.

Knowledge of Late Effects Risks and Healthcare Responsibility in Adolescents and Young Adults Treated for Childhood Cancer.

Lee JL, Gutierrez-Colina A, Williamson Lewis R, Wasilewski-Masker K, Meacham LR, Mertens AC, Gilleland Marchak J.

J Pediatr Psychol. 2019 Jun 1;44(5):557-566. doi: 10.1093/jpepsy/jsy102.

PMID:
30624691
35.

Confident and Understanding Parents (CUPs) - a child nutrition and active play pilot intervention for disadvantaged families attending Supported Playgroups in Victoria, Australia.

Myers J, Riggs E, Lee JL, Gibbons K, Naughton G.

Health Promot J Austr. 2019 Jan 8. doi: 10.1002/hpja.229. [Epub ahead of print]

PMID:
30623503
36.

Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act.

Park HY, Kim YA, Sim JA, Lee J, Ryu H, Lee JL, Maeng CH, Kwon JH, Kim YJ, Nam EM, Shim HJ, Song EK, Jung KH, Kang EJ, Kang JH, Yun YH.

J Pain Symptom Manage. 2019 Apr;57(4):774-782. doi: 10.1016/j.jpainsymman.2018.12.332. Epub 2018 Dec 27.

PMID:
30593911
37.

The impact of exercise on mitochondrial dynamics and the role of Drp1 in exercise performance and training adaptations in skeletal muscle.

Moore TM, Zhou Z, Cohn W, Norheim F, Lin AJ, Kalajian N, Strumwasser AR, Cory K, Whitney K, Ho T, Ho T, Lee JL, Rucker DH, Shirihai O, van der Bliek AM, Whitelegge JP, Seldin MM, Lusis AJ, Lee S, Drevon CA, Mahata SK, Turcotte LP, Hevener AL.

Mol Metab. 2019 Mar;21:51-67. doi: 10.1016/j.molmet.2018.11.012. Epub 2018 Dec 4.

38.

Postretrieval Relearning Strengthens Hippocampal Memories via Destabilization and Reconsolidation.

Tay KR, Flavell CR, Cassini L, Wimber M, Lee JLC.

J Neurosci. 2019 Feb 6;39(6):1109-1118. doi: 10.1523/JNEUROSCI.2618-18.2018. Epub 2018 Dec 26.

PMID:
30587543
39.

Prognostic Implications of Extranodal Extension in Relation to Colorectal Cancer Location.

Kim CW, Kim J, Park Y, Cho DH, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC.

Cancer Res Treat. 2018 Nov 29. doi: 10.4143/crt.2018.392. [Epub ahead of print]

40.

Racial and Socioeconomic Disparities in Cancer-Related Knowledge, Beliefs, and Behaviors in Indiana.

Rawl SM, Dickinson S, Lee JL, Roberts JL, Teal E, Baker LB, Kianersi S, Haggstrom DA.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):462-470. doi: 10.1158/1055-9965.EPI-18-0795. Epub 2018 Nov 28.

PMID:
30487135
41.

Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival.

Shin H, Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC.

ANZ J Surg. 2019 Jan;89(1-2):61-67. doi: 10.1111/ans.14933. Epub 2018 Nov 28.

PMID:
30484933
42.

Increased nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level.

Hong SM, Hwang SW, Wang T, Park CW, Ryu YM, Jung JH, Shin JH, Kim SY, Lee JL, Kim CW, Yoon G, Kim KH, Myung SJ, Choi KY.

Cancer Sci. 2019 Feb;110(2):629-638. doi: 10.1111/cas.13886. Epub 2018 Dec 27.

43.

Evidence for increased surveillance of executive functioning in adolescent and young adult survivors of childhood cancer.

Lee JL, Gutierrez-Colina A, Meacham LR, Mertens AC, Gilleland Marchak J.

Transl Behav Med. 2018 Nov 5. doi: 10.1093/tbm/iby100. [Epub ahead of print]

PMID:
30395335
44.

Purification and characterization of the thermostable protease produced by Serratia grimesii isolated from channel catfish.

Accumanno GM, Richards VA, Gunther NW 4th, Hickey ME, Lee JL.

J Sci Food Agric. 2019 Mar 30;99(5):2428-2437. doi: 10.1002/jsfa.9451. Epub 2018 Dec 18.

PMID:
30362163
45.

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.

Gross-Goupil M, Kwon TG, Eto M, Ye D, Miyake H, Seo SI, Byun SS, Lee JL, Master V, Jin J, DeBenedetto R, Linke R, Casey M, Rosbrook B, Lechuga M, Valota O, Grande E, Quinn DI.

Ann Oncol. 2018 Dec 1;29(12):2371-2378. doi: 10.1093/annonc/mdy454.

46.

Assessment of Water Quality Profile Using Numerical Modeling Approach in Major Climate Classes of Asia.

Iqbal MM, Shoaib M, Farid HU, Lee JL.

Int J Environ Res Public Health. 2018 Oct 15;15(10). pii: E2258. doi: 10.3390/ijerph15102258.

47.

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.

Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA.

Korean J Intern Med. 2018 Oct 12. doi: 10.3904/kjim.2018.064. [Epub ahead of print]

48.

Creative Arts-Based Therapies for Stroke Survivors: A Qualitative Systematic Review.

Lo TLT, Lee JLC, Ho RTH.

Front Psychol. 2018 Sep 20;9:1646. doi: 10.3389/fpsyg.2018.01646. eCollection 2018.

49.

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.

Ansari AA, Park I, Kim I, Park S, Ahn SM, Lee JL.

BMC Med Genomics. 2018 Oct 3;11(1):88. doi: 10.1186/s12920-018-0406-2.

50.

Supplemental Content

Support Center